Dyne Therapeutics Chief Medical Officer Kerr Douglas sold 5,035 shares in two transactions priced from $18.88 to $24.35 per share, leaving him with 162,564 shares. The transaction gives investors a current view of an insider’s remaining ownership and the prices attached to the reported sales.

Key Highlights

  • Kerr Douglas held 162,564 Dyne Therapeutics shares after the transactions.
  • The sales occurred across two transactions between September 4 and September 8, 2026.
  • Both transactions carried SEC transaction code S, classifying them as open-market sales.

Dyne Therapeutics, Inc. (NASDAQ: DYN) Chief Medical Officer Kerr Douglas sold 5,035 shares at prices ranging from $18.88 to $24.35 per share. The two transactions leave Douglas with 162,564 shares of Dyne Therapeutics.

The sales took place between September 4 and September 8, 2026. The reported price range was $18.88 to $24.35 per share. Douglas remains a holder of Dyne Therapeutics stock after the transactions. His reported post-transaction ownership stands at 162,564 shares.